Keyphrases
Flutamide
100%
Multiple Myeloma
100%
Imexon
100%
Human Tumors
100%
Hydrocortisone
50%
Suramin
37%
Aminoglutethimide
37%
Prostate-specific Antigen
25%
Hormone-sensitive Prostate Cancer
25%
Surgical Castration
25%
Prostate Cancer
12%
Cancer Cells
12%
Prolonged Exposure
12%
Androgen Receptor
12%
Anemia
12%
Thrombocytopenia
12%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
12%
Best Medical Treatment
12%
Simultaneous Administration
12%
Bone Scan
12%
Pretreated Patients
12%
Previous Treatment
12%
Depot
12%
Soft Tissue Disease
12%
Adrenal Insufficiency
12%
Androgenic
12%
Leuprolide
12%
Enactive Approach
12%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Flutamide
100%
Multiple Myeloma
100%
Imexon
100%
Hydrocortisone
50%
Prostate Cancer
37%
Suramin
37%
Aminoglutethimide
37%
Malignant Neoplasm
25%
Prostate Specific Antigen
25%
Symptom
12%
Long Term Exposure
12%
Androgen Receptor
12%
Epileptic Absence
12%
Anemia
12%
Thrombocytopenia
12%
Castration Resistant Prostate Cancer
12%
Soft Tissue Disease
12%
Adrenal Insufficiency
12%
Leuprorelin
12%
Medicine and Dentistry
Flutamide
100%
Suramin
37%
Leuprorelin
12%